The medical industry is one of the most capital-intensive sectors in the American economy, and the tax code rewards that investment in ways many healthcare organizations never fully capture.
If you own medical real estate, develop or renovate healthcare facilities, or run a business investing in clinical innovation, three IRS-compliant strategies can significantly reduce your tax burden and improve cash flow:
- Cost Segregation: accelerate depreciation on medical properties and recover capital faster
- Section 179D: claim meaningful deductions for energy-efficient building systems in new construction and renovations
- R&D Tax Credits: earn dollar-for-dollar tax credits for qualifying innovation and development activities
Together, these strategies can represent substantial savings, and they’re more accessible than most healthcare executives and property owners realize. Here’s what each one means for your organization.
Cost Segregation: Accelerate Depreciation on Medical Properties
When a medical facility is purchased, constructed, or significantly renovated, the IRS typically requires the entire building to be depreciated over 39 years as commercial real estate. That’s a long time to wait for a return on a substantial capital investment.
Cost segregation changes that equation.
A cost segregation study is an engineering-based tax analysis that identifies and reclassifies specific components of a commercial property; things like specialized plumbing, electrical systems, flooring, exam room millwork, and other interior improvements; from 39-year depreciation schedules to much shorter lives of 5, 7, or 15 years. The result is significantly accelerated depreciation deductions in the early years of ownership, which translates directly into improved cash flow.
Why medical properties are especially well-suited for cost segregation:
Medical and healthcare facilities tend to have a higher percentage of reclassifiable components than standard commercial buildings. Consider what goes into a medical office building, ambulatory surgery center, imaging facility, or specialty clinic:
- Specialized electrical systems to power diagnostic and imaging equipment
- Medical-grade plumbing and piping configurations
- Custom cabinetry, millwork, and built-in fixtures in exam and procedure rooms
- Enhanced HVAC and ventilation systems required for clinical environments
- Flooring, wall coverings, and finishes specific to healthcare use
- Security, communications, and nurse call systems
These components often represent a significant share of total construction or acquisition cost, and they’re precisely the types of assets that qualify for accelerated depreciation under a properly conducted cost segregation study.
Whether you own a single medical office building or a portfolio of healthcare properties, cost segregation can unlock deductions you’re currently leaving on the table. And with bonus depreciation provisions still available for qualifying assets, the timing of a study matters.
Who should consider a cost segregation study?
If your organization owns, has recently acquired, or has constructed a medical facility in the last several years, or has a renovation in progress, a cost segregation analysis is worth exploring. Studies can even be performed retroactively on properties owned for multiple years, allowing you to catch up on missed deductions without amending prior returns.
Section 179D: A Tax Deduction Built for Energy-Efficient Medical Buildings
The Section 179D deduction rewarded commercial building owners and developers who invested in energy-efficient systems, and for over a decade it was one of the most valuable incentives available in healthcare real estate.
Under the deduction, qualifying energy-efficient improvements to commercial buildings, including medical facilities, could be worth up to $5.81 per square foot. Qualifying systems included interior lighting, HVAC, and the building envelope (roofing, insulation, windows, and exterior doors), applying to new construction, renovations, and retrofits.
What’s changed:
Under the One Big Beautiful Bill Act (OBBBA), Section 179D sunset for any building or system where construction began after June 30, 2026. If your project broke ground on or before that date, it may still qualify, provided it meets the applicable energy performance thresholds and is properly documented. For projects that started construction after June 30, 2026, the deduction is no longer available.
Why this still matters for healthcare developers and owners:
Medical facilities, by their very nature, are designed with energy-intensive systems. Advanced HVAC configurations are required to maintain sterile environments and precise temperature controls. Lighting systems must meet strict clinical standards. These aren’t design choices made for luxury; they’re operational necessities. For projects that qualify under the pre-sunset rules, the deduction can still represent a significant benefit on a large-scale facility.
For a 50,000-square-foot medical building meeting maximum qualification thresholds, that could represent a deduction of more than $280,000; a meaningful reduction in taxable income.
Don’t overlook retroactive opportunities:
Even with the sunset in place, building owners with qualifying projects placed in service in prior years may still be able to claim previously unclaimed 179D deductions through a lookback study, often without the need to amend a prior return. If your organization has completed a construction or renovation project involving energy systems in recent years, it’s worth assessing whether a Section 179D lookback study could unlock a deduction you haven’t yet claimed.
Who qualifies for Section 179D?
Private owners of commercial medical buildings, real estate investors, and developers with projects that began construction on or before June 30, 2026, or with existing buildings eligible for a retroactive lookback study, may still be eligible. Designers of record on government-owned or tax-exempt facilities with qualifying pre-sunset projects may also qualify. A no-cost analysis can help determine where your project stands.
R&D Tax Credits: Rewarding Innovation in Medicine
The Research and Development tax credit is one of the most powerful, and most misunderstood, incentives in the tax code. Many companies in the medical industry assume the R&D credit is reserved for large pharmaceutical companies or academic research institutions. In reality, it applies to a much broader range of activities than most business owners realize.
The federal R&D tax credit provides a dollar-for-dollar reduction in tax liability, not just a deduction, for qualifying research activities. That distinction matters. A tax credit directly offsets what you owe, making it one of the highest-value incentives available to innovation-driven businesses.
What qualifies as R&D in the medical industry?
Under the IRS’s four-part test, qualifying research must involve a process of experimentation, be technological in nature, aim to eliminate uncertainty, and be related to the development or improvement of a product, process, software, or formula. In the medical space, this encompasses a wide range of activities that organizations are likely already conducting, including:
- Medical device development and improvement: designing, prototyping, testing, and iterating on new or enhanced devices
- Clinical software and health technology: developing proprietary software platforms, electronic health record systems, diagnostic tools, or patient monitoring applications
- Formulation and process development: pharmaceutical companies and biotech firms developing or improving drug formulations, manufacturing processes, or delivery mechanisms
- Testing and validation: conducting technical trials, simulations, or evaluations to verify that a product or process meets clinical or regulatory performance standards
- Custom equipment and tooling: engineering specialized equipment or instrumentation for clinical, laboratory, or surgical applications
Even companies that don’t think of themselves as “research companies” may qualify if they are investing resources in solving technical problems, improving how existing products or processes work, or developing new clinical capabilities.
The financial impact:
The federal R&D credit is calculated based on qualified research expenses; including wages for employees engaged in qualifying activities, contractor costs, and supply expenses. For growing medical businesses, the credit can represent hundreds of thousands of dollars in annual tax savings. Many states offer additional R&D credits on top of the federal benefit, increasing the total value further.
For eligible startup companies and small businesses, the R&D credit can also be applied against payroll taxes, making it accessible even for organizations not yet generating significant taxable income.
The Bottom Line: These Benefits Work Together
What makes tax planning in the medical industry particularly compelling is that these three strategies are not mutually exclusive. A healthcare organization that owns its building, invests in energy-efficient systems, and conducts qualifying research may be eligible for all three; cost segregation, Section 179D, and the R&D tax credit; simultaneously.
Together, they can represent a substantial reduction in tax burden and a meaningful improvement in cash flow. That’s capital that can be reinvested in patient care, facility expansion, equipment acquisition, or further innovation.
The key is having the right team to identify what you qualify for, conduct the analysis with the rigor required to withstand IRS scrutiny, and deliver results that are both maximized and defensible.
Work with a Team That Knows Medical
At CSSI Services, we’ve spent more than 23 years conducting engineering-based tax studies for commercial property owners and businesses across industries, including healthcare. Our team brings the technical depth and tax law expertise needed to identify every dollar of benefit you’re entitled to, delivered in a way that’s clear, compliant, and built to last.
If you own medical real estate, are developing or renovating a healthcare facility, or run a business in the medical industry investing in innovation, now is the right time to understand what’s available to you.
Request a free analysis today and find out how much your organization may qualify for.
